Email This Article

Investors Display Allergic Reaction to Sepracor
By Adam Feuerstein
03/07/02 - 07:42 PM EST
The stock is decimated as the company bristles over the FDA's rejection of the allergy drug Soltara.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,289.06 1,090.05 2,169.85 34.33
Oil *
72.29
UP
3.09
DOWN
1.88
DOWN
3.14
UP
0.41
10 Yr
3.43%
SPDR Gold
109.95
+0.03%
-0.17%
-0.14%
+1.21%
Data delayed 20 minutes

Brokerage Partners